|
|
Botulism poisoningBotulism is a life threatening paralytic disease caused by the Clostridium botulinum neurotoxin. It can be caused by botulism poisoning with food which contains botulinum toxin or by botulism poisoning through an open wound. The toxin is produced by CB which contaminates traumatic wounds or causes infant botulism. Cb can be get in the gastrointestinal tract and start developing botulism. Etiology
Epidemiology process eventsThe disease has a sporadic evolution, or family or community outbreaks. The incidence per 100,000 persons in 1998 was 0.18 in UK and 0.28 in the west of the country. DiagnosisClinical diagnosis Incubation: 12-48-hour, rarely up to 6-8 days, the diagnosis for botulism poisoning is as difficult as short as the incubation is. Onset: 24-48 hours, loss of appetite, nausea, abdominal pain, diarrhea, constipation, flatulence. State of the patient suffering from botulism poisoning is characterized by:
The mood is sometimes altered with insomnia, but consciousness is preserved. Evolution, clinical forms resulting from botulism poisoning
Healing is slow, paresis and paralysis are healed in months and the accommodation disorders may require correction by glasses. Prognosis
Laboratory diagnosis confirms clinical suspicion of botulism poisoning by highlighting the presence of botulinum toxin in serum, stool, stomach content, vomiting and very rarely the bacillus toxin is found in faeces. Pathological products: blood, suspect food and feces. Harvested products are sent to reference laboratories. Bacteriological diagnosis
The biological sample on laboratory mice allows the identification and even titration of botulinum toxin in patient's serum. The method consists of injecting the patient's serum (collected sterile) in equal doses, intraperitoneally, in several pairs of mice, one partner from each pair being previously protected with a known dose of botulinum antitoxin (7 antigenic types denoted A to F ). Within 24 hours a single mouse will survive, namely the one protected with antitoxin serum corresponding to the patient's toxin. The faster this identification is being made, the greater the chances therapeutic. The patient will be given monovalent serum toxin exactly matching the type of the toxin, even if he was initially given polyvalent antitoxin serum. Epidemiological data
Prevention and controlMeasures against the source of infection Screening: epidemiological, clinical and laboratory Declaring: nominal monthly Isolation: immediate internment, isolation is not necessary. |
|